Point-of-Care Diagnostics, Blood Assay Development & Validation, Quantitative Proteomics

"Biological Intelligence for National Health and Mission Readiness."

Proteas Health Inc is a U.S.-based biotechnology company founded in 2020 and incorporated in Delaware with operations in California. Proteas Health delivers the BioTAS system, an advanced blood analysis platform designed for temporal health monitoring, earlier disease detection, risk stratification, and systemic drug effect monitoring. BioTAS integrates across defense, public health, and federal research environments to strengthen national readiness and evidence-based decision-making.

Our mission

Proteas Health advances national health and mission readiness through deployable blood-based intelligence that enables earlier disease detection and informed federal decision-making.